abn amro increase valuation, page-3

Are you sure.. refer attached

MARKET TALK: ABN AMRO Keeps IBA Health At Buy 31/08/06 09:56:00+

0956 [Dow Jones] STOCK CALL: ABN AMRO says IBA Health's (IBA.AU) normalized
FY net profit of A$19.3 million beats its forecast of A$16.9 million. Reported
net profit of A$15.6 million included A$3.2 million one-off restructuring cost.
"Importantly, FY07 guidance has been reconfirmed. Given the strong start to
FY07, we think this may prove conservative," broker says, adding growth in Asia
region is key. Maintains Buy rating. Target price A$1.26 vs last trade 87 cents.
(SVM)